Efficacy of apraclonidine eye drops in treating ptosis secondary to myasthenia gravis: A pilot clinical trial.

Published in: Muscle & nerve (2023)

Apraclonidine may alleviate ptosis secondary to MG and may be an effective alternative treatment for this group of patients.

Keyphrases